enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Tissue factor pathway inhibitor - Wikipedia

    en.wikipedia.org/.../Tissue_factor_pathway_inhibitor

    Tissue factor pathway inhibitor (or TFPI) is a single-chain polypeptide which can reversibly inhibit factor Xa (Xa). While Xa is inhibited, the Xa-TFPI complex can subsequently also inhibit the FVIIa-tissue factor complex. TFPI contributes significantly to the inhibition of Xa in vivo, despite being present at concentrations of only 2.5 nM.

  3. TFPI2 - Wikipedia

    en.wikipedia.org/wiki/TFPI2

    , PP5, REF1, TFPI-2, tissue factor pathway inhibitor 2: External IDs Gene ... Tissue factor pathway inhibitor 2 is a protein that in humans is encoded by the TFPI2 ...

  4. Pfizer Discontinues Hemophilia Gene Therapy Beqvez As ...

    www.aol.com/finance/pfizer-discontinues...

    Hympavzi is the first and only anti-tissue factor pathway inhibitor (anti-TFPI) ... Price Action: PFE stock is up 0.87% at $26.13 at the last check on Friday. Read Next:

  5. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    tissue factor pathway inhibitor (TFPI) Y: bleeding with hemophilia: Maslimomab: mouse: T-cell receptor: Mavrilimumab [38] mab: human: GMCSF receptor α-chain: rheumatoid arthritis: Matuzumab [24] mab: humanized: Epidermal growth factor receptor (EGFR) colorectal, lung and stomach cancer Mepolizumab [47] Bosatria: mab: humanized: IL-5: Y: asthma ...

  6. Concizumab - Wikipedia

    en.wikipedia.org/wiki/Concizumab

    The efficacy and safety of concizumab were evaluated in a multi-national, multi-center, open-label, phase III trial (NCT04083781) with 91 adult and 42 adolescent male participants with hemophilia A or B with inhibitors who have been prescribed, or are in need of, treatment with therapies that bypass the inhibitor effect. [11]

  7. Marstacimab - Wikipedia

    en.wikipedia.org/wiki/Marstacimab

    [1] [4] [2] It is a tissue factor pathway inhibitor (TFPI) antagonist. [4] It was developed by Pfizer. [5] Marstacimab is a new type of medication that, rather than replacing a clotting factor, works by reducing the amount, and therefore, the activity of, the naturally occurring anticoagulation protein called tissue factor pathway inhibitor. [4]

  8. Kunitz domain - Wikipedia

    en.wikipedia.org/wiki/Kunitz_domain

    The majority of the sequences having this domain belong to the MEROPS inhibitor family I2, clan IB; the Kunitz/bovine pancreatic trypsin inhibitor family, they inhibit proteases of the S1 family [5] and are restricted to the metazoa with a single exception: Amsacta moorei entomopoxvirus, a species of poxvirus. They are short (about 50 to 60 ...

  9. Activated protein C resistance test - Wikipedia

    en.wikipedia.org/wiki/Activated_protein_C...

    [10] [11] The aPTT-based assay is more sensitive to levels of prothrombin and factor VIII, whereas the ETP-based test is more sensitive to levels of tissue factor pathway inhibitor (TFPI) and protein S. [5]